Vimovo 500 mg/20 mg FC Tablet
PDF Leaflet Revision Date: 21 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief in rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
Dosage (summary)
1 tablet twice daily for adults.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly (> 65 years)
Pregnancy & Breastfeeding
Contraindicated in third trimester; not recommended during breastfeeding.
Key Drug Interactions
- Clopidogrel
- Warfarin
- Aspirin
- Diuretics
Contraindications
- Hypersensitivity to naproxen or esomeprazole
- Severe hepatic impairment
- Third trimester of pregnancy
Common side effects
- Diarrhoea
- Upper abdominal pain
- Constipation
- Dizziness
Counselling Points
- Take at least 30 mins before food.
- Monitor for gastrointestinal symptoms.
- Avoid use in pregnancy and breastfeeding.
Serious warnings
- Risk of gastrointestinal bleeding
- Cardiovascular thrombotic events
- Renal toxicity
Important Disclaimer
The Vimovo 500 mg/20 mg FC Tablet professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
